Yokosuka Osamu, Arai Makoto
Department of Medicine and Clinical Oncology, K1, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba, 260-8670, Japan.
Med Mol Morphol. 2006 Sep;39(3):113-20. doi: 10.1007/s00795-006-0328-5.
Hepatitis B virus (HBV) is a major cause of liver disease worldwide. It is covered with envelope (surface antigen) proteins with the nucleocapsid (core antigen) inside. In the nucleocapsid, there is an incomplete double-stranded DNA and a DNA polymerase. Four genes, S, C, X, and P, are encoded, and these partially overlap. Mutations have been reported in each gene and in their promoter regions, and these mutations can change the efficiency of HBV replication and the clinical course of patients. In this article, we review the relationship between the molecular biology of HBV and its clinical outcome.
乙型肝炎病毒(HBV)是全球肝脏疾病的主要病因。它被包膜(表面抗原)蛋白所覆盖,内部有核衣壳(核心抗原)。在核衣壳中,有一条不完全双链DNA和一种DNA聚合酶。它编码四个基因,即S、C、X和P,这些基因部分重叠。每个基因及其启动子区域均已报道存在突变,这些突变可改变HBV复制效率及患者的临床病程。在本文中,我们综述了HBV分子生物学与其临床结局之间的关系。